Internal Medicine · Mt Pleasant, SC
NPI
1093781577
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
498 Wando Park Blvd Ste 500
Mt Pleasant, SC, 29464
Phone (843) 216-8139
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
5,417 services
Medicare patients, 2024
312
Average age 76
Drug cost, 2024
$547K
6,021 prescriptions
Company payments, 2025
$116
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert S Thompson was code 99213 (office e&m - established), 592 times for 288 patients. In total Robert S Thompson billed 5,417 services in 29 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 592 | 288 | $58.41 | $35K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 258 | 258 | $122.11 | $32K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 241 | 241 | $17.54 | $4,227 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 164 | 164 | $23.89 | $3,918 |
| 96372 Injection Administration | Office | 157 | 24 | $9.19 | $1,442 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 151 | 23 | $0.84 | $127 |
| 93882 Duplex Scan - Extracranial Arteries | Office | 136 | 136 | $79.77 | $11K |
| 83036 Blood Count | Office | 61 | 46 | $9.52 | $581 |
| 99214 Office E&M - Established | Office | 52 | 46 | $91.38 | $4,752 |
| 90673 Vaccine Product | Office | 50 | 50 | $81.82 | $4,091 |
| G0008 Administration of influenza virus vaccine | Office | 50 | 50 | $30.42 | $1,521 |
| 81002 Clinical Chemistry | Office | 27 | 19 | $3.41 | $92.07 |
| 99211 Office E&M - Established | Office | 16 | 15 | $15.02 | $240 |
| 99203 Office E&M - New | Office | 11 | 11 | $75.48 | $830 |
By year: 2022 $102K for 12,304 services; 2023 $96K for 13,089 services; 2024 $102K for 5,417 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 61 | 46 | $9.52 | $581 |
| 81002 Clinical Chemistry | 27 | 19 | $3.41 | $92.07 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert S Thompson prescribed most often to Medicare patients was Rosuvastatin Calcium, with 704 prescriptions and refills. In total Robert S Thompson wrote 6,021 Medicare prescriptions that cost $547K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 704 | 1,946 | 193 | $12K |
| Ramipril Generic | 370 | 1,057 | 101 | $5,022 |
| Levothyroxine Sodium Generic | 284 | 713 | 69 | $4,209 |
| Amlodipine Besylate Generic | 249 | 645 | 64 | $1,634 |
| Metoprolol Succinate Generic | 139 | 335 | 34 | $2,415 |
| Ezetimibe Generic | 136 | 364 | 38 | $3,836 |
| Escitalopram Oxalate Generic | 114 | 257 | 26 | $1,739 |
| Pantoprazole Sodium Generic | 111 | 300 | 30 | $1,802 |
| Valsartan Generic | 94 | 254 | 24 | $3,455 |
| Pravastatin Sodium Generic | 93 | 263 | 28 | $1,059 |
| Tamsulosin Hcl Generic | 93 | 230 | 31 | $1,827 |
| Zolpidem Tartrate Generic | 92 | 140 | 20 | $627 |
| Hydrochlorothiazide Generic | 92 | 250 | 28 | $431 |
| Omeprazole Generic | 91 | 209 | 27 | $1,193 |
| Trazodone Hcl Generic | 91 | 170 | 25 | $1,149 |
Brand drugs: 712 claims; generic drugs: 5,294 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert S Thompson $116 ($116 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $42.9.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.